Skin and brain age together: The role of hormones in the ageing process

Experimental Gerontology

Volumn 45, Issue 10, 2010, Pages 801-813

  Makrantonaki, Evgenia ^a,b   Schönknecht, Peter ^c   Hossini, Amir M ^a   Kaiser, Elmar ^d   Katsouli, Myrto Maria ^a,b   Adjaye, James ^e   Schröder, Johannes ^d   Zouboulis, Christos C ^a,b  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Ageing; Alzheimer's disease; Central nervous system; Growth factors; Sex steroids; Skin

Indexed keywords

17ALPHA ESTRADIOL; 2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; ESTRADIOL VALERATE; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; GLYCOLIC ACID; GROWTH HORMONE; IBUTAMOREN; MEDROXYPROGESTERONE ACETATE; MESTRANOL; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; QUINESTROL; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA;

AGING; ALZHEIMER DISEASE; BRAIN; CELL AGING; CLINICAL TRIAL; COARSE FACE; DEGENERATIVE DISEASE; DRUG MEGADOSE; EMBRYOLOGY; GENE MUTATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOGLYCEMIA; IMMUNE SYSTEM; LOW DRUG DOSE; LYMPHOID HYPERPLASIA; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; RISK FACTOR; SKIN; SKIN DEFECT;

AGED; AGING; BRAIN; ENDOCRINE SYSTEM; HORMONES; HUMANS; SKIN PHYSIOLOGICAL PROCESSES;

EID: 77956986751     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.08.005     Document Type: Review

References (174)

1. Adashi E.Y., Resnick C.E., Svoboda M.E., Van Wyk J.J. Somatomedin-C synergizes with follicle-stimulating hormone in the acquisition of progestin biosynthetic capacity by cultured rat granulosa cells. Endocrinology 1985, 116:2135-2142.
2. Affinito P., Palomba S., Sorrentino C., Di Carlo C., Bifulco G., Arienzo M.P., Nappi C. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999, 33:239-247.
3. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 1992, 89:10114-10118.
4. Ashcroft G.S., Ashworth J.J. Potential role of estrogens in wound healing. Am. J. Clin. Dermatol. 2003, 4:737-743.
5. Ashcroft G.S., Horan M.A., Ferguson M.W. The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model. J. Anat. 1997, 190(Pt 3):351-365.
6. Ashcroft G.S., Mills S.J., Flanders K.C., Lyakh L.A., Anzano M.A., Gilliver S.C., Roberts A.B. Role of Smad3 in the hormonal modulation of in vivo wound healing responses. Wound Repair Regen. 2003, 11:468-473.
7. Atwood C.S., Meethal S.V., Liu T., Wilson A.C., Gallego M., Smith M.A., Bowen R.L. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J. Neuropathol. Exp. Neurol. 2005, 64:93-103.
8. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. USA 2000, 97:4279-4284.
9. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 1997, 51:535-541.
10. Benn P.A. Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 1976, 28:465-473.
11. Bennett A.E., Wahner H.W., Riggs B.L., Hintz R.L. Insulin-like growth factors I and II: aging and bone density in women. J. Clin. Endocrinol. Metab. 1984, 59:701-704.
12. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
13. Bishop J., Simpkins J.W. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res. Bull. 1995, 36:315-320.
14. Blanche H., Cabanne L., Sahbatou M., Thomas G. A study of French centenarians: are ACE and APOE associated with longevity?. CR Acad. Sci. III 2001, 324:129-135.
15. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
16. Boonen S., Rosen C., Bouillon R., Sommer A., McKay M., Rosen D., Adams S., Broos P., Lenaerts J., Raus J., Vanderschueren D., Geusens P. Musculoskeletal effects of the recombinant human IGF-I/lGF binding protein-3 complex in osteoporotic patients with proximal femoral 11I fracture: a double-blind, placebo-controlled pilot study. J. Clin. Endocrinol. Metab. 2002, 87:1593-1599.
17. Brincat M.P. Hormone replacement therapy and the skin. Maturitas 2000, 35:107-117.
18. Burger H.G., Dudley E.C., Cui J., Dennerstein L., Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab. 2000, 85:2832-2838.
19. Burton J.L., Libman L.J., Cunliffe W.J., Wilkinson R., Hall R., Shuster S. Sebum excretion in acromegaly. Br. Med. J. 1972, 1:406-408.
20. Callens A., Vaillant L., Lecomte P., Berson M., Gall Y., Lorette G. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996, 193:289-294.
21. Carro E., Torres-Aleman I. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?. Expert Rev. Neurother. 2004, 4:79-86.
22. Carro E., Torres-Aleman I. Serum insulin-like growth factor I in brain function. Keio J. Med. 2006, 55:59-63.
23. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 2002, 8:1390-1397.
24. Carro E., Trejo J.L., Gerber A., Loetscher H., Torrado J., Metzger F., Torres-Aleman I. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol. Aging 2006, 27:1250-1257.
25. Carroll P.V., Christ E.R., Bengtsson B.A., Carlsson L., Christiansen J.S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., Sonksen P.H., Tanaka T., Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 1998, 83:382-395.
26. Cecchi C., Fiorillo C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., Nassi P., Liguri G. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic. Biol. Med. 2002, 33:1372-1379.
27. Chau D., Mancoll J.S., Lee S., Zhao J., Phillips L.G., Gittes G.K., Longaker M.T. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann. Plast. Surg. 1998, 40:490-493.
28. Chen W., Yang C.C., Sheu H.M., Seltmann H., Zouboulis C.C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J. Invest. Dermatol. 2003, 121:441-447.
29. Chernausek S.D., Backeljauw P.F., Frane J., Kuntze J., Underwood L.E. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J. Clin. Endocrinol. Metab. 2007, 92:902-910.
30. Christensen K., Johnson T.E., Vaupel J.W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 2006, 7:436-448.
31. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
32. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 1993, 14:20-39.
33. Deplewski D., Rosenfield R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999, 140:4089-4094.
34. D'Ercole A.J., Stiles A.D., Underwood L.E. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 1984, 81:935-939.
35. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
36. Dunn L.B., Damesyn M., Moore A.A., Reuben D.B., Greendale G.A. Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Arch. Dermatol. 1997, 133:339-342.
37. Duong T., Nikolaeva M., Acton P.J. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 1997, 749:152-156.
38. Effros R.B. Ageing and the immune system. Novartis Found. Symp. 2001, 235:130-139. discussion 139-45, 146-9.
39. Elias P.M., Ghadially R. The aged epidermal permeability barrier: basis for functional abnormalities. Clin. Geriatr. Med. 2002, 18:103-120. vii.
40. Faiman C., Winter J.S. Diurnal cycles in plasma FSH, testosterone and cortisol in men. J. Clin. Endocrinol. Metab. 1971, 33:186-192.
41. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Bremner W.J., McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 2002, 87:589-598.
42. Fernandez-Tresguerres Hernandez J.A. Effects of hormones on aging of the CNS, the immune system and the skin in rats. An. Real Acad. Nac. Med. (Madr.) 2004, 121:157-176. discussion 176-9.
43. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
44. Flachsbart F., Caliebe A., Kleindorp R., Blanche H., von Eller-Eberstein H., Nikolaus S., Schreiber S., Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. USA 2009, 106:2700-2705.
45. Franceschi C., Bonafe M., Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000, 18:1717-1720.
46. Fritsch M., Orfanos C.E., Zouboulis C.C. Sebocytes are the key regulators of androgen homeostasis in human skin. J. Invest. Dermatol. 2001, 116:793-800.
47. Fuchs K.O., Solis O., Tapawan R., Paranjpe J. The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study. Cutis 2003, 71:481-488.
48. Gardner E.M., Murasko D.M. Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology 2002, 3:271-290.
49. Giacomoni P.U., Rein G. A mechanistic model for the aging of human skin. Micron 2004, 35:179-184.
50. Giannoulis M.G., Sonksen P.H., Umpleby M., Breen L., Pentecost C., Whyte M., McMillan C.V., Bradley C., Martin F.C. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2006, 91:477-484.
51. Gilchrest B.A. Age-associated changes in the skin. J. Am. Geriatr. Soc. 1982, 30:139-143.
52. Gilchrest B.A. In vitro assessment of keratinocyte aging. J. Invest. Dermatol. 1983, 81:184s-189s.
53. Gilliver S.C., Ashcroft G.S. Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 2007, 10:276-288.
54. Gilliver S.C., Ruckshanthi J.P., Atkinson S.J., Ashcroft G.S. Androgens influence expression of matrix proteins and proteolytic factors during cutaneous wound healing. Lab. Invest. 2007, 87:871-881.
55. Goyarts E., Muizzuddin N., Maes D., Giacomoni P.U. Morphological changes associated with aging: age spots and the microinflammatory model of skin aging. Ann. NY Acad. Sci. 2007, 1119:32-39.
56. Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 1991, 73:1016-1025.
57. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv. Immunol. 2002, 80:243-284.
58. Guevara-Aguirre J., Vasconez O., Martinez V., Martinez A.L., Rosenbloom A.L., Diamond F.B., Gargosky S.E., Nonoshita L., Rosenfeld R.G. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J. Clin. Endocrinol. Metab. 1995, 80:1393-1398.
59. Guevara-Aguirre J., Rosenbloom A.L., Vasconez O., Martinez V., Gargosky S.E., Allen L., Rosenfeld R.G. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. J. Clin. Endocrinol. Metab. 1997, 82:629-633.
60. Guroff G. Nerve growth factor as a neurotrophic agent. Ann. NY Acad. Sci. 1993, 692:51-59.
61. Guy R., Ridden C., Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J. Invest. Dermatol. 1996, 106:454-460.
62. Han V.K., Hill D.J., Strain A.J., Towle A.C., Lauder J.M., Underwood L.E., D'Ercole A.J. Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Pediatr. Res. 1987, 22:245-249.
63. Hardman M.J., Emmerson E., Clarke L., Ashcroft G.S. Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomised female mice. Endocrinology 2007.
64. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
65. Hawkins M.B., Thornton J.W., Crews D., Skipper J.K., Dotte A., Thomas P. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc. Natl. Acad. Sci. USA 2000, 97:10751-10756.
66. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 1965, 37:614-636.
67. Henderson V.W. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am. J. Med. 1997, 103:11S-18S.
68. Herzog V., Kirfel G., Siemes C., Schmitz A. Biological roles of APP in the epidermis. Eur. J. Cell Biol. 2004, 83:613-624.
69. Hollis E.R., Lu P., Blesch A., Tuszynski M.H. IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury. Exp. Neurol. 2009, 215:53-59.
70. Ida N., Hartmann T., Pantel J., Schroder J., Zerfass R., Forstl H., Sandbrink R., Masters C.L., Beyreuther K. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 1996, 271:22908-22914.
71. Ikawa A., Ishii Y., Suzuki K., Yasoshima A., Suzuki N., Nakayama H., Takahashi S., Doi K. Age-related changes in the dorsal skin histology in Mini and Wistar rats. Histol. Histopathol. 2002, 17:419-426.
72. Iwamoto N., Nishiyama E., Ohwada J., Arai H. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci. Lett. 1994, 177:23-26.
73. Jaffe A.B., Toran-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 1994, 269:13065-13068.
74. Jensen M., Schroder J., Blomberg M., Engvall B., Pantel J., Ida N., Basun H., Wahlund L.O., Werle E., Jauss M., Beyreuther K., Lannfelt L., Hartmann T. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann. Neurol. 1999, 45:504-511.
75. Johnson J.K., McCleary R., Oshita M.H., Cotman C.W. Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. Brain Res. 1998, 798:18-24.
76. Jong Y.J., Ford S.R., Seehra K., Malave V.B., Baenziger N.L. Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation. FASEB J. 2003, 17:2319-2321.
77. Kanda N., Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci. 2005, 38:1-7.
78. Kosmadaki M.G., Gilchrest B.A. The role of telomeres in skin aging/photoaging. Micron 2004, 35:155-159.
79. Kvetnoi I.M., Kvetnaia T.V., Riadnova I., Fursov B.B., Ernandes-Jago H., Blesa J.R. Expression of beta-amyloid and tau-protein in mastocytes in Alzheimer disease. Arkh. Patol. 2003, 65:36-39.
80. Labrie F., Belanger A., Luu-The V., Labrie C., Simard J., Cusan L., Gomez J.L., Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998, 63:322-328.
81. Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?. Mech. Ageing Dev. 2005, 126:305-307.
82. Lee K.S., Oh K.Y., Kim B.C. Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. J. Dermatol. Sci. 2000, 23:103-110.
83. Lener T., Moll P.R., Rinnerthaler M., Bauer J., Aberger F., Richter K. Expression profiling of aging in the human skin. Exp. Gerontol. 2006, 41:387-397.
84. Lewis D.A., Travers J.B., Somani A.K., Spandau D.F. The IGF-1/IGF-1 R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene 2010, 29:1475-1485.
85. Li Y., Liu L., Barger S.W., Griffin W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 2003, 23:1605-1611.
86. Linton P.J., Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 2004, 5:133-139.
87. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89:484-490.
88. Lustig R.H. Sex hormone modulation of neural development in vitro. Horm. Behav. 1994, 28:383-395.
89. Ly D.H., Lockhart D.J., Lerner R.A., Schultz P.G. Mitotic misregulation and human aging. Science 2000, 287:2486-2492.
90. Makrantonaki E., Zouboulis C.C. William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology 2007, 214:352-360.
91. Makrantonaki E., Zouboulis C.C. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br. J. Dermatol. 2007, 156:428-432.
92. Makrantonaki E., Zouboulis C.C. Molecular mechanisms of skin aging: state of the art. Ann. NY Acad. Sci. 2007, 1119:40-50.
93. Makrantonaki E., Zouboulis C.C. Androgens and ageing of the skin. Curr. Opin. Endocrinol. Diab. Obes. 2009, 16:240-245.
94. Makrantonaki E., Adjaye J., Herwig R., Brink T.C., Groth D., Hultschig C., Lehrach H., Zouboulis C.C. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell 2006, 5:331-344.
95. Makrantonaki E., Vogel K., Fimmel S., Oeff M., Seltmann H., Zouboulis C.C. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp. Gerontol. 2008, 43:939-946.
96. Marcus R., Hoffman A.R. Growth hormone as therapy for older men and women. Annu. Rev. Pharmacol. Toxicol. 1998, 38:45-61.
97. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
98. Masters B.A., Raizada M.K. Insulin-like growth factor I receptors and IGF-I actions in neuronal cultures from the brain. Ann. NY Acad. Sci. 1993, 692:89-101.
99. Menon G.K., Feingold K.R., Moser A.H., Brown B.E., Elias P.M. De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J. Lipid Res. 1985, 26:418-427.
100. Michikawa Y., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999, 286:774-779.
101. Miquel J. An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp. Gerontol. 1998, 33:113-126.
102. Mooradian A.D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 1993, 45:509-511.
103. Mooradian A.D. Mechanisms of age-related endocrine alterations. Part I. Drugs Aging 1993, 3:81-97.
104. Moreau M., Leclerc C. The choice between epidermal and neural fate: a matter of calcium. Int. J. Dev. Biol. 2004, 48:75-84.
105. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1992, 1:345-347.
106. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., Adem A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement. Geriatr. Cogn. Disord. 1999, 10:446-451.
107. Nebel A., Flachsbart F., Till A., Caliebe A., Blanche H., Arlt A., Hasler R., Jacobs G., Kleindorp R., Franke A., Shen B., Nikolaus S., Krawczak M., Rosenstiel P., Schreiber S. A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech. Ageing Dev. 2009, 130:691-699.
108. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995, 6:99-107.
109. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59:551-555.
110. 2+]i-level of fibroblasts from Alzheimer patients and control individuals. Neurochem. Res. 2001, 26:817-820.
111. Pantel J., Schroder J., Jauss M., Essig M., Minakaran R., Schonknecht P., Schneider G., Schad L.R., Knopp M.V. Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease. Psychiatry Res. 1999, 90:181-192.
112. Papadakis M.A., Grady D., Black D., Tierney M.J., Gooding G.A., Schambelan M., Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 1996, 124:708-716.
113. Patriarca M.T., Goldman K.Z., Dos Santos J.M., Petri V., Simoes R.S., Soares J.M., Simoes M.J., Baracat E.C. Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007, 130:202-205.
114. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp. Gerontol. 2000, 35:1317-1325.
115. Phillips T.J., Symons J., Menon S. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. J. Am. Acad. Dermatol. 2008, 59(397-404):e3.
116. Plackett T.P., Boehmer E.D., Faunce D.E., Kovacs E.J. Aging and innate immune cells. J. Leukoc. Biol. 2004, 76:291-299.
117. Plowden J., Renshaw-Hoelscher M., Engleman C., Katz J., Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004, 3:161-167.
118. Pochi P.E., Strauss J.S., Downing D.T. Age-related changes in sebaceous gland activity. J. Invest. Dermatol. 1979, 73:108-111.
119. Punnonen R., Vaajalahti P., Teisala K. Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women. Ann. Chir. Gynaecol. Suppl. 1987, 202:39-41.
120. Qiu C., De Ronchi D., Fratiglioni L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 2007, 20:380-385.
121. Riedl M., Kotzmann H., Luger A. Growth hormone in the elderly man. Wien. Med. Wochenschr. 2001, 151:426-429.
122. Rittie L., Kang S., Voorhees J.J., Fisher G.J. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. Arch. Dermatol. 2008, 144:1129-1140.
123. Robinson M.K., Binder R.L., Griffiths C.E. Genomic-driven insights into changes in aging skin. J. Drugs Dermatol. 2009, 8:s8-s11.
124. Rosenbloom A.L. Mecasermin (recombinant human insulin-like growth factor I). Adv. Ther. 2009, 26:40-54.
125. Rosenfield R.L., Deplewski D., Kentsis A., Ciletti N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998, 196:43-46.
126. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama 2002, 288:321-333.
127. Rudman D., Feller A.G., Nagraj H.S., Gergans G.A., Lalitha P.Y., Goldberg A.F., Schlenker R.A., Cohn L., Rudman I.W., Mattson D.E. Effects of human growth hormone in men over 60years old. N. Engl. J. Med. 1990, 323:1-6.
128. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 2007, 28:20-47.
129. Sator P.G., Schmidt J.B., Sator M.O., Huber J.C., Honigsmann H. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 2001, 39:43-55.
130. Sator P.G., Sator M.O., Schmidt J.B., Nahavandi H., Radakovic S., Huber J.C., Honigsmann H. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric 2007, 10:320-334.
131. Scali C., Prosperi C., Bracco L., Piccini C., Baronti R., Ginestroni A., Sorbi S., Pepeu G., Casamenti F. Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease. Neurobiol. Aging 2002, 23:523-530.
132. Schmidt J.B. Perspectives of estrogen treatment in skin aging. Exp. Dermatol. 2005, 14:156.
133. Schneider E.L., Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. USA 1976, 73:3584-3588.
134. Schonknecht P., Lutjohann D., Pantel J., Bardenheuer H., Hartmann T., von Bergmann K., Beyreuther K., Schroder J. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci. Lett. 2002, 324:83-85.
135. Schonknecht P., Pantel J., Hartmann T., Werle E., Volkmann M., Essig M., Amann M., Zanabili N., Bardenheuer H., Hunt A., Schroder J. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry Res. 2003, 120:231-238.
136. Schonknecht P., Pantel J., Kruse A., Schroder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am. J. Psychiatry 2005, 162:2071-2077.
137. Schonknecht P., Pantel J., Kaiser E., Thomann P., Schroder J. Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia. Neurosci. Lett. 2007, 416:39-42.
138. Sevigny J.J., Ryan J.M., van Dyck C.H., Peng Y., Lines C.R., Nessly M.L. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology 2008, 71:1702-1708.
139. Shin M.H., Rhie G.E., Park C.H., Kim K.H., Cho K.H., Eun H.C., Chung J.H. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J. Invest. Dermatol. 2005, 124:315-323.
140. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Jama 2004, 291:2947-2958.
141. Singh R., Kolvraa S., Rattan S.I. Genetics of human longevity with emphasis on the relevance of HSP70 as candidate genes. Front. Biosci. 2007, 12:4504-4513.
142. Smith J.R., Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996, 273:63-67.
143. Smyth C.D., Gosden R.G., McNeilly A.S., Hillier S.G. Effect of inhibin immunoneutralization on steroidogenesis in rat ovarian follicles in vitro. J. Endocrinol. 1994, 140:437-443.
144. Smythe C.D., Greenall M., Kealey T. The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol. J. Invest. Dermatol. 1998, 111:139-148.
145. Sumino H., Ichikawa S., Abe M., Endo Y., Nakajima Y., Minegishi T., Ishikawa O., Kurabayashi M. Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocr. J. 2004, 51:159-164.
146. Svensson J., Diez M., Engel J., Wass C., Tivesten A., Jansson J.O., Isaksson O., Archer T., Hokfelt T., Ohlsson C. Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J. Endocrinol. 2006, 189:617-627.
147. Tan Z.S., Seshadri S. Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?. Alzheimers Res. Ther. 2010, 2:6.
148. Tan Z.S., Beiser A.S., Vasan R.S., Roubenoff R., Dinarello C.A., Harris T.B., Benjamin E.J., Au R., Kiel D.P., Wolf P.A., Seshadri S. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007, 68:1902-1908.
149. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348:429-432.
150. Tavakkol A., Elder J.T., Griffiths C.E., Cooper K.D., Talwar H., Fisher G.J., Keane K.M., Foltin S.K., Voorhees J.J. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J. Invest. Dermatol. 1992, 99:343-349.
151. Tavakkol A., Varani J., Elder J.T., Zouboulis C.C. Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch. Dermatol. Res. 1999, 291:643-651.
152. Tham A., Sparring K., Bowen D., Wetterberg L., Sara V.R. Insulin-like growth factors and somatomedin B in the cerebrospinal fluid of patients with dementia of the Alzheimer type. Acta Psychiatr. Scand. 1988, 77:719-723.
153. Thienhaus O.J., Zemlan F.P., Bienenfeld D., Hartford J.T., Bosmann H.B. Growth hormone response to edrophonium in Alzheimer's disease. Am. J. Psychiatry 1987, 144:1049-1052.
154. Thornton M.J., Nelson L.D., Taylor A.H., Birch M.P., Laing I., Messenger A.G. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?. J. Invest. Dermatol. 2006, 126:2010-2018.
155. Tomlinson J.W., Holden N., Hills R.K., Wheatley K., Clayton R.N., Bates A.S., Sheppard M.C., Stewart P.M. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001, 357:425-431.
156. Tresini M., Lorenzini A., Torres C., Cristofalo V.J. Modulation of replicative senescence of diploid human cells by nuclear ERK signaling. J. Biol. Chem. 2007, 282:4136-4151.
157. Tsukahara K., Kakuo S., Moriwaki S., Hotta M., Ohuchi A., Kitahara T., Harada N. The characteristics of aromatase deficient hairless mice indicate important roles of extragonadal estrogen in the skin. J. Steroid Biochem. Mol. Biol. 2008, 108:82-90.
158. Uberti D., Carsana T., Bernardi E., Rodella L., Grigolato P., Lanni C., Racchi M., Govoni S., Memo M. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. J. Cell Sci. 2002, 115:3131-3138.
159. Uberti D., Lanni C., Carsana T., Francisconi S., Missale C., Racchi M., Govoni S., Memo M. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. Neurobiol. Aging 2006, 27:1193-1201.
160. Urabe M., Yamamoto T., Kashiwagi T., Okubo T., Tsuchiya H., Iwasa K., Kikuchi N., Yokota K., Hosokawa K., Honjo H. Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocr. J. 1996, 43:737-742.
161. Urbanelli L., Emiliani C., Massini C., Persichetti E., Orlacchio A., Pelicci G., Sorbi S., Hasilik A., Bernardi G., Orlacchio A. Cathepsin D expression is decreased in Alzheimer's disease fibroblasts. Neurobiol. Aging 2008, 29:12-22.
162. van Exel E., Eikelenboom P., Comijs H., Frolich M., Smit J.H., Stek M.L., Scheltens P., Eefsting J.E., Westendorp R.G. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease. Arch. Gen. Psychiatry 2009, 66:1263-1270.
163. Vance M.L. Can growth hormone prevent aging?. N. Engl. J. Med. 2003, 348:779-780.
164. Veldhuis J.D., Anderson S.M., Kok P., Iranmanesh A., Frystyk J., Orskov H., Keenan D.M. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women. J. Clin. Endocrinol. Metab. 2004, 89:1312-1318.
165. Willcox B.J., Donlon T.A., He Q., Chen R., Grove J.S., Yano K., Masaki K.H., Willcox D.C., Rodriguez B., Curb J.D. FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. USA 2008, 105:13987-13992.
166. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
167. Woolley C.S., McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-d-aspartate receptor-dependent mechanism. J. Neurosci. 1994, 14:7680-7687.
168. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 1998, 4:447-451.
169. Yaar M., Gilchrest B.A. Human melanocytes as a model system for studies of Alzheimer disease. Arch. Dermatol. 1997, 133:1287-1291.
170. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. Jama 1998, 279:688-695.
171. Ye J., Garg A., Calhoun C., Feingold K.R., Elias P.M., Ghadially R. Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp. Dermatol. 2002, 11:209-216.
172. Zouboulis C.C. Human skin: an independent peripheral endocrine organ. Horm. Res. 2000, 54:230-242.
173. Zouboulis Ch C. Intrinsic skin aging. A critical appraisal of the role of hormones. Hautarzt 2003, 54:825-832.
174. Zouboulis C.C., Chen W.C., Thornton M.J., Qin K., Rosenfield R. Sexual hormones in human skin. Horm. Metab. Res. 2007, 39:85-95.